Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06662435Not ApplicableCompleted

GYNecologic Cancer-Related COGnitive Impairment

Role: collaborator

NCT03841513Not ApplicableCompleted

Minimally Invasive Burch Colposuspension to Reduce Occult Stress Incontinence

Role: collaborator

NCT06523569Not ApplicableRecruiting

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

Role: collaborator

NCT03505424Not ApplicableCompleted

Supporting All Families of Premature Infants At Prentice Women's Hospital from Admission Through Discharge

Role: collaborator

NCT06139757Recruiting

Sleep Length and Euploid Embryo Transfer Prospective Study

Role: collaborator

NCT02678377Phase 4Completed

The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence

Role: collaborator

All 6 trials loaded